Miriam Steets~~Jared N. Fertman~~Joe Laurel~~Denise Klasen
January 24, 2026
Willkie Advises Goldman Sachs Alternatives on €120 Million Series B Investment in osapiens

1 min
AI-made summary
- Willkie advised Goldman Sachs Alternatives on a €120 million Series B investment in osapiens, a Germany-based ESG platform specializing in compliance and sustainability reporting solutions
- Osapiens, which employs over 300 people and serves more than 1,300 customers globally, completed the $120 million financing round led by Goldman Sachs Alternatives' Growth Equity division
- The Willkie legal team was led by partner Miriam Steets, with support from Jared Fertman, Joe Laurel, and Denise Kammerer.
Willkie recently advised Goldman Sachs Alternatives on its €120 million Series B investment in osapiens, a leading ESG platform and provider of compliance and sustainability reporting solutions.
On July 29, osapiens announced on the completion of a $120 million Series B financing round led by Growth Equity at Goldman Sachs Alternatives. Based in Germany, osapiens is a leading provider of ESG software solutions and works with an international team of more than 300 employees for more than 1,300 customers worldwide.
Goldman Sachs (NYSE: GS) is one of the leading investors in alternatives globally, with over $450 billion in assets and more than 30 years of experience. The business invests in the full spectrum of alternatives including private equity, growth equity, private credit, real estate, infrastructure, hedge funds and sustainability.
The Willkie team was led by partner Miriam Steets and included partner Jared Fertman and associates Joe Laurel and Denise Kammerer.
Article Author
Miriam Steets~~Jared N. Fertman~~Joe Laurel~~Denise Klasen
The Sponsor
